Han‐Chang Huang

1.5k total citations
33 papers, 1.3k citations indexed

About

Han‐Chang Huang is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Han‐Chang Huang has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 16 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Han‐Chang Huang's work include Alzheimer's disease research and treatments (21 papers), Curcumin's Biomedical Applications (7 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). Han‐Chang Huang is often cited by papers focused on Alzheimer's disease research and treatments (21 papers), Curcumin's Biomedical Applications (7 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). Han‐Chang Huang collaborates with scholars based in China and United States. Han‐Chang Huang's co-authors include Zhao-Feng Jiang, Xueling Dai, Ke Xu, Hong Liang, Ke Xu, Changjun Lin, Bowen Zheng, Shuyan Lu, Zhun Wang and Xuemei Gu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Food and Chemical Toxicology and Journal of Alzheimer s Disease.

In The Last Decade

Han‐Chang Huang

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han‐Chang Huang China 18 670 501 232 177 168 33 1.3k
Zhao-Feng Jiang China 22 750 1.1× 544 1.1× 248 1.1× 172 1.0× 175 1.0× 31 1.4k
Sachin Patil United States 18 380 0.6× 472 0.9× 138 0.6× 70 0.4× 170 1.0× 43 1.3k
Maria Sapienza Italy 10 494 0.7× 655 1.3× 105 0.5× 86 0.5× 168 1.0× 10 1.4k
Rajeswara Babu Mythri India 14 342 0.5× 409 0.8× 135 0.6× 318 1.8× 265 1.6× 20 1.2k
Chainarong Tocharus Thailand 22 267 0.4× 473 0.9× 144 0.6× 91 0.5× 122 0.7× 74 1.4k
Stephanie Hagl Germany 17 382 0.6× 424 0.8× 126 0.5× 89 0.5× 103 0.6× 24 911
Dana J. Gant United States 4 521 0.8× 189 0.4× 134 0.6× 122 0.7× 160 1.0× 4 709
Mychica Jones United States 10 491 0.7× 322 0.6× 150 0.6× 383 2.2× 171 1.0× 13 988
Xiaohong Zuo China 10 375 0.6× 199 0.4× 125 0.5× 184 1.0× 190 1.1× 15 770
Teresa Chu United States 11 766 1.1× 607 1.2× 320 1.4× 492 2.8× 371 2.2× 13 1.8k

Countries citing papers authored by Han‐Chang Huang

Since Specialization
Citations

This map shows the geographic impact of Han‐Chang Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Chang Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Chang Huang more than expected).

Fields of papers citing papers by Han‐Chang Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han‐Chang Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Chang Huang. The network helps show where Han‐Chang Huang may publish in the future.

Co-authorship network of co-authors of Han‐Chang Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Chang Huang. A scholar is included among the top collaborators of Han‐Chang Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Chang Huang. Han‐Chang Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Wenxuan, et al.. (2025). APOE4-driven lipid metabolic dysregulation in Alzheimer's disease: Multi-pathway mechanisms and therapeutic perspectives. Biochemical and Biophysical Research Communications. 778. 152335–152335. 1 indexed citations
3.
Huang, Han‐Chang, et al.. (2024). Astaxanthin Prevents Oxidative Damage and Cell Apoptosis Under Oxidative Stress Involving the Restoration of Mitochondrial Function. Cell Biochemistry and Function. 42(8). e70027–e70027. 2 indexed citations
4.
5.
Song, Xijun, et al.. (2021). Phosphorylation and Glycosylation of Amyloid-β Protein Precursor: The Relationship to Trafficking and Cleavage in Alzheimer’s Disease. Journal of Alzheimer s Disease. 84(3). 937–957. 13 indexed citations
6.
7.
Li, Mengjie, et al.. (2020). Independent and Correlated Role of Apolipoprotein E ɛ 4 Genotype and Herpes Simplex Virus Type 1 in Alzheimer’s Disease. Journal of Alzheimer s Disease. 77(1). 15–31. 6 indexed citations
8.
Wei, Jun, et al.. (2018). Protective Effect of Zeaxanthin against Tunicamycin-induced Cell Damage in SH-SY5Y Cell. Food Science and Technology Research. 24(6). 1101–1109. 3 indexed citations
9.
Huang, Han‐Chang, et al.. (2015). Protection of curcumin against amyloid-β-induced cell damage and death involves the prevention from NMDA receptor-mediated intracellular Ca2+elevation. Journal of Receptors and Signal Transduction. 35(5). 450–457. 25 indexed citations
10.
Huang, Han‐Chang, et al.. (2014). Endoplasmic reticulum stress as a novel neuronal mediator in Alzheimer’s disease. Neurological Research. 37(4). 366–374. 34 indexed citations
11.
Huang, Han‐Chang, Hong Liang, Jianyu Zhang, et al.. (2014). Chitooligosaccharides Attenuate Cu2+-Induced Cellular Oxidative Damage and Cell Apoptosis Involving Nrf2 Activation. Neurotoxicity Research. 27(4). 411–420. 35 indexed citations
12.
Huang, Han‐Chang, et al.. (2013). Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway. Journal of Receptors and Signal Transduction. 34(1). 26–37. 77 indexed citations
13.
Huang, Han‐Chang. (2012). Research progress of the biological activity of functional chitooligosaccharides. 1 indexed citations
14.
Huang, Han‐Chang, Ke Xu, & Zhao-Feng Jiang. (2012). Curcumin-Mediated Neuroprotection Against Amyloid-β-Induced Mitochondrial Dysfunction Involves the Inhibition of GSK-3β. Journal of Alzheimer s Disease. 32(4). 981–996. 87 indexed citations
15.
Huang, Han‐Chang, et al.. (2012). Protective Effects of Curcumin on Amyloid-β-Induced Neuronal Oxidative Damage. Neurochemical Research. 37(7). 1584–1597. 42 indexed citations
16.
Huang, Han‐Chang, Changjun Lin, Wenjuan Liu, Ruirui Jiang, & Zhao-Feng Jiang. (2011). Dual effects of curcumin on neuronal oxidative stress in the presence of Cu(II). Food and Chemical Toxicology. 49(7). 1578–1583. 45 indexed citations
17.
Gu, Xuemei, Zhao-Feng Jiang, & Han‐Chang Huang. (2010). Magnetic resonance imaging of Alzheimer’s disease: from diagnosis to therapeutic evaluation. Chinese Journal of Integrative Medicine. 16(3). 276–282. 4 indexed citations
18.
Xu, Wei, Han‐Chang Huang, Changjun Lin, & Zhao-Feng Jiang. (2010). Chitooligosaccharides protect rat cortical neurons against copper induced damage by attenuating intracellular level of reactive oxygen species. Bioorganic & Medicinal Chemistry Letters. 20(10). 3084–3088. 35 indexed citations
19.
Huang, Han‐Chang & Zhao-Feng Jiang. (2009). Accumulated Amyloid-β Peptide and Hyperphosphorylated Tau Protein: Relationship and Links in Alzheimer's Disease. Journal of Alzheimer s Disease. 16(1). 15–27. 240 indexed citations
20.
Yang, Xiaohui, Han‐Chang Huang, Lin Chen, Wei Xu, & Zhao-Feng Jiang. (2009). Coordinating to Three Histidine Residues: Cu(II) Promotes Oligomeric and Fibrillar Amyloid-β Peptide to Precipitate in a Non-β Aggregation Manner. Journal of Alzheimer s Disease. 18(4). 799–810. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhao-Feng Jiang Breakdown of academic impact, for papers by Sachin Patil Breakdown of academic impact, for papers by Maria Sapienza Breakdown of academic impact, for papers by Rajeswara Babu Mythri Breakdown of academic impact, for papers by Chainarong Tocharus Breakdown of academic impact, for papers by Stephanie Hagl Breakdown of academic impact, for papers by Dana J. Gant Breakdown of academic impact, for papers by Mychica Jones Breakdown of academic impact, for papers by Xiaohong Zuo Breakdown of academic impact, for papers by Teresa Chu
Rankless by CCL
2026